What is the appropriate approach to evaluating and managing chronic diarrhea in a young female patient?

Approach to Chronic Diarrhea in Young Female Patient

In a young female patient with chronic diarrhea, begin with first-line blood tests (complete blood count, ferritin, tissue transglutaminase IgA, thyroid function) and stool tests (fecal calprotectin) in primary care, followed by a structured algorithmic approach based on alarm features and test results 1.

Initial Assessment and Risk Stratification

The evaluation differs fundamentally based on symptom duration and presence of alarm features. If diarrhea duration is <3 months, predominantly nocturnal, or accompanied by alarm features (unexplained weight loss, persistent blood in stool, recent change in bowel habit over 6 weeks), immediate referral for further investigation is warranted 1.

Key Historical Elements to Elicit

Focus your history on these specific factors that direct diagnosis:

• Family history of inflammatory bowel disease, coeliac disease, or neoplasia
• Previous surgery, particularly ileal resections (>100cm suggests malabsorption; <100cm suggests bile acid diarrhea)
• Medication review including recent antibiotics, NSAIDs, PPIs, metformin
• Dietary triggers: excessive caffeine, sorbitol, fructose, lactose intake
• Systemic disease: diabetes, thyroid disorders, systemic sclerosis
• Alcohol consumption (direct epithelial toxicity and pancreatic dysfunction)
• Travel history and immunocompromised status 1

Primary Care Investigations (First-Line)

The following tests should be completed before specialist referral 1:

Blood Tests

• Complete blood count and ferritin (anemia suggests malabsorption or inflammation)
• Tissue transglutaminase IgA with total IgA level (sensitivity 0.81-0.86 for coeliac disease) 2
  • If IgA deficient (6.4-7% of coeliac cases are antibody-negative), order IgG EMA or IgG TTG 1
• Thyroid function tests (hyperthyroidism)
• C-reactive protein (sensitivity 0.73, specificity 0.78 for organic disease) 2

Stool Tests

• Fecal calprotectin at cutoff 50-60 mg/g (pooled sensitivity 0.81, specificity 0.87 for inflammatory disease—this is your best discriminator) 2
• Three fresh stool samples for ova, cysts, and parasites if infectious etiology suspected (60-90% sensitivity for giardiasis) 1
• Two-stage C. difficile testing: glutamate dehydrogenase EIA or PCR first, then toxin EIA for confirmation 1

Secondary Care Evaluation

When to Refer

Refer if normal first-line investigations but symptoms severe enough to impair quality of life and not responding to empiric treatment, or if alarm features present 1.

Categorization Strategy

Use fecal calprotectin to distinguish inflammatory from non-inflammatory diarrhea 2, 3:

If Fecal Calprotectin Elevated (>50-60 mg/g)

Pursue inflammatory causes:

• Colonoscopy with biopsies for inflammatory bowel disease and microscopic colitis (often missed, requires biopsies even with normal-appearing mucosa)
• Exclude ongoing C. difficile infection
• Consider immunodeficiency workup including HIV testing in appropriate risk populations 1

If Fecal Calprotectin Normal

Categorize as watery (secretory/osmotic/functional) or fatty diarrhea:

For malabsorptive/fatty diarrhea features:

• Duodenal biopsy even if TTG negative (antibody-negative coeliac disease is 6.4-7% of cases) 1
• Stool ELISA for Giardia (92% sensitivity, 98% specificity—superior to microscopy) 1
• Consider bile acid diarrhea testing (SeHCAT scan or 7α-hydroxy-4-cholesten-3-one if available)
• Pancreatic function assessment if risk factors present

For watery diarrhea without malabsorption:

• Consider functional diarrhea/IBS-D if age <50 and all screening negative 3, 4
• Evaluate for bile acid malabsorption (responds to bile acid sequestrants)
• Screen for endocrine causes if clinically indicated

Critical Pitfalls to Avoid

1. Do not dismiss normal TTG without checking total IgA level—IgA deficiency occurs in coeliac disease and causes false-negative results 1

2. Do not rely on PCR alone for C. difficile—requires toxin confirmation to avoid overtreatment of colonization and missing post-infectious IBS 1

3. Do not skip microscopic colitis evaluation—requires random colonic biopsies even with normal-appearing mucosa on colonoscopy 3

4. In young females specifically, maintain high suspicion for coeliac disease (female predominance), microscopic colitis (female:male ratio 3:1), and functional disorders

Treatment Approach

First-line management for functional diarrhea after excluding organic causes: lifestyle modification, dietary therapy (low FODMAP assessment), probiotics, and antidiarrheals 5, 6. Specific therapies exist for coeliac disease (gluten-free diet), bile acid diarrhea (bile acid sequestrants), and microscopic colitis (budesonide), making accurate diagnosis essential for quality of life outcomes.